Jane Street Group, LLC Aligos Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 13,666 shares of ALGS stock, worth $258,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,666
Holding current value
$258,287
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.35 - $1.07 $4,783 - $14,622
13,666 New
13,666 $4,000
Q1 2023

May 15, 2023
BUY
$0.87 - $2.11 $8,551 - $20,739
9,829 Added 59.86%
26,249 $22,000
Q4 2022

Feb 14, 2023
BUY
$0.89 - $28.0 $14,613 - $459,760
16,420 New
16,420 $15,000

Others Institutions Holding ALGS

# of Institutions
3
Shares Held
253K
Call Options Held
0
Put Options Held
0
View Full List

About Aligos Therapeutics, Inc.

ALGS Quotes by TradingView
  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $751M
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email